Initially identified as an alternative oestrogen receptor in breast cancer [169], GPER signalling has emerged as a significant player in colon cancer [170], contributing to various aspects of tumour progression and estrogenic cell signalling responses [171]. Here, GPER1 is linked to breast cancer.